This is the downloadable manual in five languages to accompany the Country Commodity Manager (CCM), a software program that helps UNFPA Country Offices assess their reproductive health commodity requirements, stock positions and identify shortfalls. CCM also provides a mechanism to readily transmit each country's data to UNFPA headquarters from their country offices for use in generating global level reports for the purposes of planning, advocacy and resource mobilization.

This report, which is prepared on an annual basis, provides a detailed look at the contraceptive supplies provided by donors. Based on data collected by UNFPA's Commodity Management Branch since 1990, the report presents information on the type, quantity and total cost of contraceptives that donors have been supplying to reproductive health programmes in developing countries. The report also analyzes trends in donor funding over the last decade and compares the supply of contraceptive commodities with estimated needs.

In addition to providing a list of essential reproductive health supplies, this guidebook outlines the steps necessary for including reproductive health medicines on country-level lists of essential medicines. It also highlights the consequences of poor reproductive health and the importance of devoting resources to its betterment and reviews the concept of essential medicines lists and their significance.

The purpose of the booklet is to provide factual information that can be used to foster a positive attitude towards condom use. The message is kept simple and focused on responding to common, reoccurring myths, misperceptions, and fears related to condoms and condom use. It provides accurate evidence-based information to support the fact that consistent use of male or female condoms is highly effective at preventing unintended pregnancy, the transmission of HIV and other sexually transmitted infections.

Although the female condom has been on the market for more than ten years, the supply and adoption of this device, which protects against both pregnancy and sexually transmitted infections, is still too low to have an impact on the AIDS epidemic. This publication, a follow up to the 2005 Global Consultation on the Female Condom, answers key questions about the female condom. It presents evidence about its effectiveness and impact, identifies challenges to wider use and suggests steps to strengthen condom programming worldwide.

This revised Interagency List of Essential Medicines for Reproductive Health presents the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance, national procurement and reimbursement schemes of these medicines.